1. Elucidation of the regulatory mechanism of renin-angiotensin-aldosterone system and its involvement in the pathogenesis.
2. Regulation of salt and body fluid in pathophysiological conditions
3. In vivo imaging in kidneys
4. Development of cancer therapy targeting the (pro)renin receptor.
5. Elucidation of the involvement of cell senescence in renal diseases
6. Elucidation of the involvement of sympathetic nerve activity in the development of hypertension in cardiovascular and renal diseases
7. Evaluation of the pharmacological properties of novel drugs.
    -detail in our English home page-

• Nishiyama A, et al. Blood pressure adaptation in vertebrates: Comparative biology. Kidney Int. 2022, In-press.
• Marton A, at al. Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation. Nat Rev Nephrol. 2021; 17(1): 65-77.
• Kidoguchi S, et al. New concept of onco-hypertension and future perspectives. Hypertension. 2021; 77(1): 16-27.

 >> Lab Homepage